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Abstract 
Background: Low birth weight is associated with increased rates of obesity, insulin resistance and type 2 diabetes, 
but the precise mechanisms for this association remain unclear. We aimed to assess the relationships between birth 
weight and markers of glucose homeostasis or obesity in adults.
Methods: Cross‑sectional population‑based study on 1458 women and 1088 men aged 35–75 years living in 
Lausanne, Switzerland. Birth weight was self‑reported and categorized into ≤2.5, 2.6–3.5, 3.6–4.0 and >4.0 kg. Body 
composition was assessed by bioimpedance. Leptin and adiponectin levels were measured by ELISA.
Results: Women with low birth weight (≤2.5 kg) had higher levels of fasting plasma glucose, insulin, HOMA, diabe‑
tes and metabolic syndrome; a non significant similar trend was seen in men. In both genders, height increased with 
birth weight, whereas a U‑shaped association was found between birth weight and body mass index, waist circum‑
ference and body fat percentage. After adjusting for age, smoking status, physical activity and fat mass, an inverse 
association was found between leptin and birth weight categories: adjusted mean ± standard error 17.3 ± 0.7, 
16.2 ± 0.3, 15.6 ± 0.5 and 14.0 ± 0.8 ng/dL for birth weight categories ≤2.5, 2.6–3.5, 3.6–4.0 and >4.0 kg, respectively, 
in women (p < 0.05) and 9.8 ± 0.8, 9.1 ± 03, 7.8 ± 0.4 and 7.7 ± 0.5 ng/dL in men (p < 0.05). An inverse associa‑
tion was also found between reported birth weight and leptin to fat mass ratio: mean ± standard error 0.77 ± 0.04, 
0.73 ± 0.02, 0.69 ± 0.03 and 0.62 ± 0.04 in women (p < 0.05); 0.46 ± 0.05, 0.45 ± 0.02, 0.39 ± 0.02 and 0.38 ± 0.03 in 
men (p < 0.05). No differences in adiponectin levels were found between birth weight groups.
Conclusions: Middle‑aged adults born with a low weight present a higher prevalence of diabetes and obesity and 
also higher leptin levels and leptin to fat mass ratio than adults born with a normal weight. The higher leptin levels 
and leptin to fat mass ratio among adults born with a low weight might be related to nutritional factors during child‑
hood or to the development of leptin resistance and/or higher leptin production by body fat unit. Subjects born with 
a low weight should be counselled regarding the risks of developing diabetes and/or cardiovascular disease.
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Background
Low birth weight is associated with increased rates of 
obesity, insulin resistance and type 2 diabetes [1], which 
are components of the metabolic syndrome [2]. Albeit 
the precise mechanisms for this association remain 
unclear, metabolic changes that could be related to 
alterations in body composition can be found already in 
childhood [3]. For instance, people with low birth weight 
present with higher plasma leptin concentrations than 
would be expected from their degree of obesity [4, 5]. In 
children born with a low birth weight, leptin levels are 
increased after catch-up growth during childhood [6], 
but it is unclear what happens during later life. Further, 
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it has been suggested that blood cord adiponectin levels 
are positively related with birth weight and BMI in new-
borns [7], with a subsequent increase in the risk of type 2 
diabetes [8]; still, this statement has also been challenged 
[9]. Overall, whether leptin and adiponectin mediate the 
effects of low birth weight on obesity, insulin resistance 
and type 2 diabetes is unclear.
Altogether, to our knowledge, no study has ever 
assessed the associations between birth weight, diabetes 
and fat mass, and leptin or adiponectin levels in middle 
age people. Hence, in this study, we assessed the associa-
tions between birth weight, markers of glucose homeo-
stasis, obesity, leptin and adiponectin levels using a 




The CoLaus Study is a prospective population-based 
study aimed at assessing the prevalence and deciphering 
the molecular determinants of cardiovascular risk fac-
tors in the population of Lausanne, Switzerland, a town 
of 117,161 inhabitants, of which 79,420 are of a Swiss 
nationality. Its sampling procedure has been described 
previously [10]. Briefly, the complete list of Lausanne 
inhabitants aged 35–75  years was provided by the pop-
ulation registry of the city. A simple, non-stratified ran-
dom sample of 35 % of the overall population was drawn. 
Caucasian origin was defined as having both parents 
and grandparents born in a restricted list of countries 
(available from the authors). The following inclusion 
criteria were applied: (a) written informed consent; (b) 
aged 35–75 years and (c) willingness to take part in the 
examination and donate blood sample. Recruitment for 
the baseline survey began in June 2003 and ended in May 
2006.
Clinical data
All participants attended the outpatient clinic of the 
University Hospital of Lausanne in the morning after an 
overnight fast. Data were collected by trained field inter-
viewers in a single visit lasting about 60 min.
Body weight and height were measured with partici-
pants standing without shoes in light indoor clothes. 
Body weight was measured in kilograms to the nearest 
100 g using a Seca® scale, which was calibrated regularly. 
Height was measured to the nearest 5 mm using a Seca® 
height gauge. BMI was defined as weight (kg) divided by 
height (m) squared. Overweight and obesity were defined 
as previously described [11]. Waist circumference was 
measured with a non-stretchable tape over the unclothed 
abdomen at the mid-point between the lowest rib and 
the iliac crest. Two measures were made and the mean 
(expressed in cm) used for analyses. Abdominal obesity 
was defined as a waist circumference ≥88 cm for women 
and ≥102 cm in men.
Fat and fat-free mass (in percent of total body weight) 
were assessed by electrical bioimpedance in the lying 
position after a 5-min rest using the Bodystat® 1500 body 
mass analyzer (Bodystat Ltd, Isle of Man, England). This 
device has been shown to correlate well (r = 0.968) with 
measurements from dual energy X-ray absorptiometry 
(DEXA) [12]. In a subset of 794 women who were also 
screened for osteoporosis using DEXA, the correlation 
between fat mass estimated by bioimpedance and DEXA 
was 0.852 (p < 0.001), with only a slight overestimation by 
BIA relative to DEXA (+0.9  kg). Participants had to be 
fasting, avoid strenuous physical activity during the pre-
vious 12 h and abstain from consuming caffeine or alco-
hol-containing beverages during 24 h before the analysis. 
All metallic adornments were removed, and measure-
ment was performed after a 10-min rest in the lying posi-
tion. The electrodes were positioned in the right side of 
the body according to the manufacturer’s instructions. 
Care was taken to ensure that the participants did not 
touch any metallic component of the bed and that the 
inner part of the thighs did not touch each other. Results 
were expressed as (%BF) and body fat mass was calcu-
lated as weight x %BF and expressed in kg.
Weight at birth was asked to all participants and 
expressed in kg. Four birth weight categories were cre-
ated: ≤2.5, 2.6–3.5, 3.6–4.0 and >4.0 kg. No information 
regarding gestational age at birth, term or preterm birth 
was collected. Smoking status was classified as never, 
former and current smokers. A participant was consid-
ered as physically active if he/she practiced at least twice 
per week leisure-time physical activities with a minimal 
duration of 20  min. Menopausal status in women was 
defined by a positive answer to the question “are you 
already menopaused?”.
Biological data
Venous blood samples (50 ml) were drawn in the fasting 
state. Fasting plasma glucose and insulin were measured, 
and the homeostasis model assessment index of insulin 
resistance (HOMA) was calculated [13]. High HOMA 
index was defined if >2.6. Diabetes was defined as fast-
ing plasma glucose ≥7.0 mmol/L or presence of oral or 
injectable hypoglycaemic treatment. Metabolic syndrome 
was defined using the Third Adult Treatment Panel 
(ATP-III) criteria [2]. Total adiponectin was assessed 
by ELISA (R&D Systems, Inc., Minneapolis, USA), with 
a maximum inter-assay coefficient of variation (CV) of 
8.3 % and a maximum intra-assay CV of 8.3 %. Leptin was 
also assessed by ELISA (American Laboratory Products 
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Company, Windham, USA) with a maximum inter-assay 
CV of 12.8 % and a maximum intra-assay CV of 5.8 %.
Statistical analyses
Statistical analyses were conducted using Stata v.14 (Stata 
Corp, College Station, TX, USA) and stratified by gender. 
Descriptive results were expressed as number of par-
ticipants and (percentage) or as mean ± standard devia-
tion. Bivariate analysis was conducted using Chi square 
test for categorical variables and using Student’s t test or 
one-way analysis of variance (ANOVA) for quantitative 
values. For continuous variables, post hoc pairwise com-
parisons using the method of Scheffe were performed 
when the results of the ANOVA were statistically signifi-
cant. Multivariable analysis was conducted using logistic 
regression for binary dependent variables, and the results 
were expressed as odds-ratio and (95 % confidence inter-
val); for quantitative variables, multivariable ANOVA 
was used and the results were expressed as adjusted 
mean ±  standard error. The leptin to fat mass ratio was 
computed as previously described [14, 15]. Because lep-
tin and adiponectin concentrations are skewed, natural 
log transformation was performed prior to analysis.
Ethics, consent and permissions
The CoLaus Study was approved by the Institutional Eth-
ics Committee of the University of Lausanne. All partici-




Of the initial 6733 participants, 2546 (37.8  %) reported 
information on birth weight and were thus included 
in the study. The characteristics of the included and 
excluded participants are summarized in Additional 
file 1: Table S1.
Sample’s characteristics
Clinical characteristics according to gender are summa-
rized in Table  1. Age was similar between women and 
men. Women reported lower tobacco consumption, had 
a lower BMI and higher body fat levels and were less fre-
quently overweight and obese than men. Women also 
reported lower birth weights and had higher leptin and 
adiponectin levels than men. Of the 2546 participants 
included in the analysis, 2404 (94.4  %) were considered 
as Caucasian.
Birth weight and obesity markers
Bivariate associations between anthropometric mark-
ers and birth weight group are summarized in Table  2 
(for women) and Table  3 (for men). All anthropometric 
markers showed significant differences between birth 
weight categories in both genders, with the exception of 
total fat mass in men (Table 3). Conversely, leptin levels 
did not differ between birth weight categories.
The results of the multivariate analysis of the associa-
tions between anthropometric markers and birth weight 
categories are summarized in Table  4 (for women) and 
Table 5 (for men). The inverse associations between birth 
weight and height or weight persisted in both genders. In 
women, both low and high birth weights were associated 
with a lower likelihood of presenting with normal weight 
in adulthood, while birth weights >3.5  kg were associ-
ated with a higher likelihood of developing abdominal 
obesity (Table  4). In men, a similar but nonsignificant 
inverse association was found between low birth weight 
and likelihood of presenting with normal weight in adult-
hood, and similar associations between birth weights 
>3.5  kg and normal weight or abdominal obesity were 
found (Table 5). A significant inverse association was also 
found between reported birth weight and the leptin to fat 
Table 1 Clinical characteristics of participants, by gender
Results are expressed as mean ± standard deviation or number of people and 
(percentage). Normal weight was defined as a body mass index (BMI) < 25 kg/
m2 ; abdominal obesity was defined as a waist circumference ≥88 cm for 
women and ≥102 cm in men. Between-gender comparisons performed using 
Student’s t test or Chi square
NR not relevant
Women (n = 1458) Men (n = 1088) p value
Age (years) 50.2 ± 10.1 49.7 ± 9.9 0.197
BMI (kg/m2) 24.5 ± 4.8 26.4 ± 3.9 <0.001
BMI categories (%) <0.001
 Normal 907 (62.2) 429 (39.4)
 Overweight 375 (25.7) 491 (45.1)
 Obese 176 (12.1) 168 (15.4)
Waist circumference 
(cm)
82.0 ± 12.4 95.0 ± 11.2 <0.001
Abdominal obesity (%) 409 (28.1) 269 (24.8) 0.062
Body fat (%) 33.0 ± 8.0 22.9 ± 6.0 <0.001
Physically active (%) 855 (58.6) 611 (56.2) 0.210
Menopausal status (%) 632 (43.4) NR
Smoking status <0.001
 Never 694 (47.6) 385 (35.4)
 Former 384 (26.3) 384 (35.3)
 Current 380 (26.1) 319 (29.3)
Birth weight (kg) 3.3 ± 1.0 3.5 ± 0.7 <0.001
Birth weight  
categories (%)
<0.001
 ≤2.5 kg 174 (11.9) 73 (6.7)
 2.6–3.5 kg 891 (61.1) 556 (51.1)
 3.6–4.0 kg 264 (18.1) 266 (24.5)
 >4.0 kg 129 (8.9) 193 (17.7)
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mass ratio in both women and men, while no differences 
in adiponectin levels were found between birth weight 
groups (Tables  4, 5). Sensitivity analysis restricting to 
people reporting a birth weight  >  1.5  kg led to similar 
findings (Additional file 1: Tables S2a, S2b). 
Birth weight and markers of glucose homeostasis
Bivariate associations between markers of glucose home-
ostasis and birth weight group are summarized in Table 2 
(for women) and Table  3 (for men). Fasting glucose, 
insulin and HOMA levels and prevalence of diabetes 
and metabolic syndrome showed significant differences 
between birth weight categories in women (Table 2) but 
not in men (Table 3).
The results of the multivariate analysis of the associa-
tions between markers of glucose homeostasis and birth 
weight categories are summarized in Table 4 (for women) 
and Table 5 (for men). In women, low birth weight was 
associated with a higher likelihood of developing diabe-
tes, insulin resistance (as assessed by high HOMA levels) 
and metabolic syndrome (Table 4). Conversely, no signifi-
cant associations were found in men, with the exception 
that birth weights >4.0 kg were associated with a higher 
likelihood of developing metabolic syndrome (Table  5). 
Sensitivity analysis restricting to people reporting a birth 
weight >1.5  kg led to similar findings, low birth weight 
being now also significantly associated with diabetes in 
men (Additional file 1: Table S2a, b).
Discussion
To our knowledge, this is the largest population-based 
study to assess the associations between birth weight and 
adult levels of markers of glucose homeostasis, obesity, lep-
tin and adiponectin in Europe. Our findings provide some 
insight regarding the differential effects of low and high 
birth weight on diabetes and obesity markers in later life.
Table 2 Distribution of anthropometric and biological variables according to birth weight, women, unadjusted
Results are expressed as number of people and (column percentage), as average ± standard deviation. Normal weight was defined as a body mass index <25 kg/
m2 ; abdominal obesity was defined as a waist circumference ≥88 cm for women and ≥102 cm in men. Between-group comparisons performed using Chi square for 
categorical variables and by ANOVA for continuous variables. For continuous variables, post hoc pairwise comparisons using the method of Scheffe were performed 
when the results of the ANOVA were statistically significant; results with a different subscript are significantly different at p < 0.05 (corrected for multiple comparisons). 
For fasting insulin and HOMA, no pairwise difference at p < 0.05 (corrected for multiple comparisons) was found
§ Statistical analysis performed on log-transformed data
Birth weight categories (kg) p value
−2.5] (n = 174) ]2.5–3.5] (n = 891) ]3.5–4.0] (n = 264) ]4.0+ (n = 129)
Anthropometry
 Height (cm) 161 ± 1a 164 ± 1b 165 ± 1c 166 ± 1c <0.001
 Weight (kg) 64.7 ± 1.0a 64.6 ± 0.4a 69.2 ± 0.8b 69.9 ± 1.1b <0.001
 BMI (kg/m2) 25.0 ± 0.4a, b 24.1 ± 0.2a 25.4 ± 0.3b 25.5 ± 0.4b <0.001
 Waist circumference (cm) 83.7 ± 0.9a, b 80.8 ± 0.4a 83.4 ± 0.8b 84.6 ± 1.1b <0.001
 Fat (% of body weight) 34.4 ± 0.6a 32.3 ± 0.3b 33.5 ± 0.5a, b 34.1 ± 0.7a, b 0.002
 Fat mass (kg) 22.9 ± 0.7a, b 21.4 ± 0.3a 24.1 ± 0.6b 24.4 ± 0.8b <0.001
BMI categories (%) <0.001
 Normal 98 (56.3) 592 (66.4) 150 (56.8) 67 (51.9)
 Overweight 48 (27.6) 220 (24.7) 68 (25.8) 39 (30.2)
 Obesity 28 (16.1) 79 (8.9) 46 (17.4) 23 (17.8)
Abdominal obesity (%) 57 (32.8) 220 (24.7) 83 (31.4) 49 (38.0) 0.002
Adipokines
 Leptin (ng/dL) 18.1 ± 0.9 15.4 ± 0.4 16.9 ± 0.7 15.9 ± 1.1 0.230§
 Leptin/fat mass ratio 0.77 ± 0.04a 0.72 ± 0.02a, b 0.71 ± 0.03a, b 0.61 ± 0.04b 0.035
 Adiponectin (μg/dL) 11.8 ± 0.7 12.2 ± 0.3 11.9 ± 0.5 12.5 ± 0.8 0.612§
Markers of glucose homeostasis
 Fasting glucose (mmol/L) 5.46 ± 0.06a 5.24 ± 0.03b 5.28 ± 0.05a, b 5.30 ± 0.07a, b 0.013
 Fasting insulin (μU/mL) 8.5 ± 0.4 7.3 ± 0.2 8.4 ± 0.3 6.9 ± 0.5 0.003
 HOMA 2.10 ± 0.12 1.76 ± 0.05 2.05 ± 0.10 1.68 ± 0.14 0.004
 Diabetes (%) 11 (6.3) 17 (1.9) 7 (2.7) 6 (4.7) 0.007
 High HOMA (%) 35 (24.3) 117 (16.5) 37 (18.5) 15 (15.2) 0.133
 Metabolic syndrome (%) 39 (22.4) 113 (12.7) 37 (14.0) 21 (16.3) 0.009
Page 5 of 10Jornayvaz et al. Cardiovasc Diabetol  (2016) 15:73 
Here, we report higher levels in markers of glucose 
homeostasis in people reporting low birth weight, but 
also a U-shaped association between birth weight and 
most obesity markers, notably among women. Those 
findings are in agreement with the literature [1, 16, 17], 
and indicate that low birth weight is associated with 
increased risk of diabetes and obesity in later life.
Birth weight and obesity markers
Leptin is a hormone produced by the adipose tissue 
and is classically increased in type 2 diabetes [18], but 
is mostly associated with obesity [19]. Diet early in life 
might regulate leptin levels [15], which in turn will influ-
ence energy intake and risk of obesity [4]. In this study, 
adult leptin levels decreased consistently with increased 
birth weight in both genders; those findings are in agree-
ment with some studies [4, 5] but not with other smaller 
sized studies, none of which being population-based 
(Jaquet et  al. (case–control study, N =  26 cases and 25 
controls, age = 24 years) [20]; Melo et al. N = 165, not 
population-based, only women) [21]). Similarly, the lep-
tin to fat mass ratio significantly decreased with increas-
ing birth weight in both gender, a finding that, to our 
knowledge, had not been reported previously. Overall, 
the decrease in leptin levels and in the leptin to fat mass 
ratio with birth weight suggest that the mechanisms by 
which low or high birth weight influence the develop-
ment of obesity in later life might be different. Interest-
ingly, it has been suggested that children born with a 
low weight develop high leptin levels during catch-up 
growth, which suggests leptin resistance [22]. Hence, 
our data suggest that the high leptin levels observed at 
birth and during childhood for low birth children could 
actually be maintained in later life. Another possible 
mechanism would be adipocyte dysfunction: catch-up 
growth is associated with adipocyte hypertrophy in male 
rats [23], hypertrophic adipocytes or adipocytes from 
low birth weight animals have a distinct gene expres-
sion [24] and high leptin levels are more closely associ-
ated with adipose cell hypertrophy than with adipose 
Table 3 Distribution of anthropometric and biological variables according to birth weight, men, unadjusted
Results are expressed as number of people and (column percentage) or as average ± standard deviation. Normal weight was defined as a body mass index <25 kg/
m2 ; abdominal obesity was defined as a waist circumference ≥88 cm for women and ≥102 cm in men. Statistical analysis by Chi square for categorical variables and 
by ANOVA for continuous variables. For continuous variables, post hoc pairwise comparisons using the method of Scheffe were performed when the results of the 
ANOVA were statistically significant; results with a different subscript are significantly different at p < 0.05 (corrected for multiple comparisons)
§ Statistical analysis performed on log-transformed data
Birth weight categories (kg) p value
−2.5] (n = 73) ]2.5–3.5] (n = 556) ]3.5–4.0] (n = 266) ]4.0+ (n = 193)
Anthropometry
 Height (cm) 175 ± 1a, c 175 ± 1a 178 ± 1b, c 179 ± 1b <0.001
 Weight (kg) 80.8 ± 1.5a, c 80.0 ± 0.6a 84.5 ± 0.8b, c 87.0 ± 0.9b <0.001
 BMI (kg/m2) 26.3 ± 0.5a 26.0 ± 0.2a 26.8 ± 0.2b 27.2 ± 0.3b <0.001
 Waist circumference (cm) 94.8 ± 1.3a, b 93.8 ± 0.5b 95.9 ± 0.7a, b 97.4 ± 0.8a <0.001
 Fat (% of body weight) 23.5 ± 0.7 22.5 ± 0.3 23.2 ± 0.4 23.6 ± 0.4 0.089
 Fat mass (kg) 19.3 ± 0.9a, b 18.4 ± 0.3b 20.1 ± 0.5a, b 21.0 ± 0.5a <0.001
BMI categories (%) 0.004
 Normal 28 (38.4) 248 (44.6) 99 (37.2) 54 (28.0)
 Overweight 33 (45.2) 236 (42.5) 120 (45.1) 102 (52.9)
 Obesity 12 (16.4) 72 (13.0) 47 (17.7) 37 (19.2)
Abdominal obesity (%) 15 (20.6) 124 (22.3) 68 (25.6) 62 (32.1) 0.043
Adipokines
 Leptin (ng/dL) 10.0 ± 1.0 8.6 ± 0.4 8.2 ± 0.5 8.7 ± 0.6 0.635§
 Leptin/fat mass ratio 0.46 ± 0.05 0.45 ± 0.02 0.39 ± 0.02 0.38 ± 0.03 0.097
 Adiponectin (μg/dL) 8.1 ± 0.7 7.2 ± 0.2 7.1 ± 0.4 7.3 ± 0.4 0.848§
Markers of glucose homeostasis
 Fasting glucose (mmol/L) 5.80 ± 0.14 5.64 ± 0.05 5.67 ± 0.07 5.60 ± 0.08 0.655
 Fasting insulin (μU/mL) 10.0 ± 0.9 9.5 ± 0.3 9.0 ± 0.5 9.5 ± 0.5 0.745
 HOMA 2.79 ± 0.3 2.45 ± 0.11 2.42 ± 0.15 2.50 ± 0.18 0.712
 Diabetes (%) 9 (12.3) 33 (5.9) 17 (6.4) 11 (5.7) 0.202
 High HOMA (%) 18 (29.5) 139 (29.8) 63 (27.9) 46 (27.7) 0.938
 Metabolic syndrome (%) 17 (23.3) 134 (24.1) 64 (24.1) 61 (31.6) 0.183
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tissue hyperplasia [25]. Nevertheless, these findings in 
animals are not corroborated in cultured preadipocytes 
isolated from adult people born with low birth weight. 
Indeed, these preadipocytes show reduced leptin expres-
sion and release compared to people born with a normal 
weight, suggesting impaired preadipocytes maturation 
[26]. These surprising results might be due to the fact 
that adult body weight was significantly lower in people 
born with a low weight compared to people born with 
a normal weight. Moreover, fat mass assessed by DEXA 
was similar between groups and this study was only per-
formed in males [26]. Finally, the high leptin to fat mass 
ratio observed in people born with a low weight could be 
a sequel of malnutrition during foetal life [27]. Overall, 
our data suggest that low birth weight leads to increased 
adult leptin levels due to the association of leptin resist-
ance and increased leptin production as assessed by the 
leptin to fat mass ratio.
High birth weight has also been shown to be related 
with obesity [28, 29], although other studies suggest that 
high birth weight is actually more related to lean than to 
fat mass (for a review, see [30]). Still, no differences in 
body fat percentage and fat mass were found between low 
and high birth weight groups in both genders, even when 
the analysis was restricted to obese people (not shown). 
Hence, the hypothesis that a high birth weight is related 
Table 4 Distribution of anthropometric and biological variables according to birth weight, women, multivariate adjusted
Results are expressed as adjusted mean ± standard error or as odds ratio and (95 % confidence interval). Normal weight was defined as a body mass index <25 kg/
m2 ; abdominal obesity was defined as a waist circumference ≥88 cm for women and ≥102 cm in men. Statistical analysis conducted using analysis of variance for 
continuous variables and logistic regression for categorical variables. Statistically significant odds ratios are indicated in italics. Column p value corresponds to the p 
value of the overall association test; column linear trend corresponds to the p value for testing a linear trend. Adjusted for: a age, smoking status and physical activity; 
b age, smoking status, physical activity and BMI; c age, smoking status, physical activity and waist circumference; d age, smoking status, physical activity and fat mass. 
Also adjusted for e antidiabetic drug treatment
§ Statistical analysis performed on log-transformed data
Birth weight categories (kg) p value Linear Quadratic
−2.5] (n = 174) ]2.5–3.5] (n = 891) ]3.5–4.0] (n = 264) ]4.0+ (n = 129)
Anthropometrya
 Height (cm) 161 ± 1 164 ± 1 165 ± 1 166 ± 1 <0.001 <0.001 0.069
 Weight (kg) 64.5 ± 1 64.7 ± 0.4 69.2 ± 0.8 69.8 ± 1.1 <0.001 <0.001 0.797
 BMI (kg/m2) 24.8 ± 0.4 24.1 ± 0.2 25.4 ± 0.3 25.4 ± 0.4 <0.001 0.086 0.285
 Waist circumference (cm) 83.1 ± 0.9 81.0.0 ± 0.4 83.5 ± 0.7 83.9 ± 1.1 0.002 0.259 0.125
 Fat (% of body weight) 33.8 ± 0.6 32.5 ± 0.2 33.6 ± 0.5 33.2 ± 0.6 0.061 0.861 0.421
 Fat mass (kg) 22.4 ± 0.7 21.6 ± 0.3 24.1 ± 0.6 23.8 ± 0.8 <0.001 0.033 0.692
 Normal weight 0.70 (0.50–0.98) 1 (ref.) 0.66 (0.50–0.88) 0.59 (0.40–0.86) 0.197 0.089
 Abdominal obesity 1.35 (0.94–1.94) 1 (ref.) 1.40 (1.03–1.90) 1.67 (1.12–2.49) – 0.206 0.106
Adipokines
 Leptin (ng/dL)a 17.8 ± 0.9 15.5 ± 0.4 16.9 ± 0.7 16.0 ± 1.1 0.357§ 0.337§ 0.522§
 Leptin (ng/dL)b 16.9 ± 0.6 16.3 ± 0.3 15.8 ± 0.5 13.8 ± 0.8 0.008§ 0.004§ 0.241§
 Leptin (ng/dL)c 16.7 ± 0.7 16.1 ± 0.3 16.1 ± 0.6 14.4 ± 0.8 0.147§ 0.050§ 0.341§
 Leptin (ng/dL)d 17.3 ± 0.7 16.2 ± 0.3 15.6 ± 0.5 14.0 ± 0.8 0.012§ 0.003§ 0.541§
 Leptin/fat mass ratiob 0.77 ± 0.04 0.73 ± 0.02 0.69 ± 0.03 0.62 ± 0.04 0.029 0.004 0.655
 Adiponectin (µg/dL)a 11.6 ± 0.7 12.3 ± 0.3 11.9 ± 0.5 12.2 ± 0.8 0.560§ 0.244 0.867
 Adiponectin (µg/dL)b 11.8 ± 0.7 12.1 ± 0.3 12.2 ± 0.5 12.5 ± 0.8 0.433§ 0.105§ 0.796§
 Adiponectin (µg/dL)c 11.9 ± 0.7 12.1 ± 0.3 12.2 ± 0.5 12.5 ± 0.8 0.594§ 0.150§ 0.800§
 Adiponectin (µg/dL)d 11.7 ± 0.6 12.1 ± 0.3 12.2 ± 0.5 12.5 ± 0.8 0.406§ 0.090§ 0.970§
Markers of glucose homeostasis
 Fasting Glucose (mmol/L)b, e 5.37 ± 0.05 5.28 ± 0.02 5.26 ± 0.04 5.18 ± 0.06 0.115 0.016 0.903
 Fasting Insulin (μU/mL)b, e 8.2 ± 0.4 7.5 ± 0.2 8.0 ± 0.3 6.5 ± 0.4 0.012 0.008 0.194
 HOMAb, e 1.99 ± 0.1 1.83 ± 0.04 1.95 ± 0.08 1.50 ± 0.12 0.006 0.004 0.106
 Diabetesb 2.43 (1.02–5.79) 1 (ref.) 0.75 (0.27–2.12) 1.40 (0.50–3.98) – 0.285 0.053
 Diabetesc 2.38 (0.97–5.84) 1 (ref.) 0.89 (0.32–2.48) 1.86 (0.65–5.29) – 0.634 0.042
 Diabetesd 2.70 (1.13–6.45) 1 (ref.) 0.71 (0.25–2.03) 1.17 (0.38–3.55) – 0.134 0.067
 High HOMAb 1.32 (0.83–2.12) 1 (ref.) 0.81 (0.51–1.28) 0.63 (0.33–1.19) – 0.031 0.947
 Metabolic syndromea 1.75 (1.15–2.68) 1 (ref.) 1.12 (0.74–1.69) 1.05 (0.62–1.79) – 0.140 0.195
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to an increased lean mass in later life is not confirmed 
by our data. Again, the precise mechanisms for the 
increased obesity risk among high birth weight children 
remain to be assessed. Maternal obesity is the most likely 
explanation, as it is related to foetal macrosomia and to 
increased risk of obesity [31, 32], although this statement 
has been challenged [33]. Indeed, the socio-economic 
position of the mother might be the strongest determi-
nant, as it is associated with a number of risk factors for 
child obesity [34]. Conversely, the reasons for lower lep-
tin and leptin to fat mass ratio in people born with a high 
weight can only be speculated. Increased birth weight is 
associated with high leptin levels [35, 36], which can be 
further reduced by breastfeeding [15]. The fact that par-
ticipants with a high birth weight also present with the 
lowest leptin levels could thus be due to differences in 
nutrition in early life, or in adipocyte metabolism [24–26] 
as assessed by a lower leptin production by body fat unit. 
Still, further studies are needed to explain those findings.
Adiponectin is another protein secreted by adipocytes. 
Reduced levels of adiponectin are observed in obese peo-
ple [37] and associated with an increased risk of type 2 
diabetes [8]. Blood cord adiponectin levels are positively 
related with birth weight and BMI in newborns [7], 
although this statement has been challenged [9]. Indeed, 
a study found lower adiponectin levels in young adults 
Table 5 Distribution of anthropometric and biological variables according to birth weight, men, multivariate adjusted
Results are expressed as adjusted mean ± standard error or as odds ratio and (95 % confidence interval). Normal weight was defined as a body mass index <25 kg/
m2 ; abdominal obesity was defined as a waist circumference ≥88 cm for women and ≥102 cm in men. Statistical analysis conducted using analysis of variance for 
continuous variables and logistic regression for categorical variables. Statistically significant odds ratios are indicated in italics. Column p value corresponds to the p 
value of the overall association test; column linear trend corresponds to the p value for testing a linear trend. Adjusted for: a age, smoking status and physical activity; 
b age, smoking status, physical activity and BMI; c age, smoking status, physical activity and waist circumference; d age, smoking status, physical activity and fat mass. 
Also adjusted for e antidiabetic drug treatment
§ Statistical analysis performed on log-transformed data
Birth weight categories (kg) p value Linear Quadratic
−2.5] (n = 73) ]2.5–3.5] (n = 556) ]3.5–4.0] (n = 266) ]4.0+ (n = 193)
Anthropometrya
 Height (cm) 175 ± 1 176 ± 1 178 ± 1 179 ± 1 <0.001 <0.001 0.306
 Weight (kg) 80.6 ± 1.5 80.0 ± 0.5 84.6 ± 0.8 86.9 ± 0.9 <0.001 <0.001 0.147
 BMI (kg/m2) 26.2 ± 0.4 26.0 ± 0.2 26.8 ± 0.2 27.1 ± 0.3 <0.001 0.024 0.328
 Waist circumference (cm) 94.8 ± 1.2 93.7 ± 0.4 96.1 ± 0.6 97.3 ± 0.8 <0.001 0.022 0.168
 Fat (% of body weight) 23.7 ± 0.6 22.4 ± 0.2 23.3 ± 0.3 23.4 ± 0.4 0.018 0.946 0.075
 Fat mass (kg) 19.4 ± 0.8 18.3 ± 0.3 20.2 ± 0.4 20.9 ± 0.5 <0.001 0.035 0.117
 Normal weight 0.75 (0.45–1.26) 1 (ref.) 0.71 (0.52–0.96) 0.47 (0.33–0.68) – 0.055 0.043
 Abdominal obesity 0.90 (0.48–1.70) 1 (ref.) 1.27 (0.89–1.82) 1.72 (1.17–2.53) – 0.039 0.610
Adipokines
 Leptin (ng/dL)a 10.0 ± 1.0 8.6 ± 0.3 8.2 ± 0.5 8.7 ± 0.6 0.649§ 0.544§ 0.209§
 Leptin (ng/dL)b 10.1 ± 0.8 9.0 ± 0.3 8.0 ± 0.4 7.9 ± 0.5 0.088§ 0.039§ 0.534§
 Leptin (ng/dL)c 10.1 ± 0.8 9.0 ± 0.3 8.0 ± 0.4 7.8 ± 0.5 0.055§ 0.031§ 0.721§
 Leptin (ng/dL)d 9.8 ± 0.8 9.1 ± 0.3 7.8 ± 0.4 7.7 ± 0.5 0.016§ 0.020§ 0.625§
 Leptin/fat mass ratiob 0.46 ± 0.05 0.45 ± 0.02 0.39 ± 0.02 0.38 ± 0.03 0.041 0.078 0.942
 Adiponectin (µg/dL)a 8.1 ± 0.7 7.2 ± 0.2 7.1 ± 0.4 7.3 ± 0.4 0.875§ 0.875§ 0.745§
 Adiponectin (µg/dL)b 8.1 ± 0.7 7.1 ± 0.2 7.1 ± 0.4 7.4 ± 0.4 0.906§ 0.827§ 0.639§
 Adiponectin (µg/dL)c 8.1 ± 0.7 7.1 ± 0.2 7.1 ± 0.4 7.5 ± 0.4 0.880§ 0.820§ 0.592§
 Adiponectin (µg/dL)d 8.1 ± 0.7 7.1 ± 0.2 7.2 ± 0.4 7.4 ± 0.4 0.898§ 0.838§ 0.577§
Markers of glucose homeostasis
 Fasting Glucose (mmol/L)b, e 5.64 ± 0.11 5.65 ± 0.04 5.68 ± 0.06 5.62 ± 0.07 0.927 0.930 0.673
 Fasting Insulin (μU/mL)b, e 9.5 ± 0.8 9.8 ± 0.3 8.8 ± 0.4 9.1 ± 0.5 0.199 0.434 0.894
 HOMAb, e 2.50 ± 0.25 2.55 ± 0.09 2.36 ± 0.13 2.39 ± 0.15 0.634 0.571 0.946
 Diabetesb 2.31 (0.96–5.60) 1 (ref.) 0.86 (0.44–1.68) 0.75 (0.36–1.59) – 0.029 0.257
 Diabetesc 2.23 (0.92–5.41) 1 (ref.) 0.88 (0.45–1.72) 0.72 (0.34–1.52) – 0.030 0.337
 Diabetesd 2.19 (0.90–5.33) 1 (ref.) 0.87 (0.44–1.71) 0.71 (0.33–1.53) – 0.032 0.352
 High HOMAb 0.84 (0.44–1.60) 1 (ref.) 0.77 (0.52–1.13) 0.67 (0.44–1.03) – 0.407 0.451
 Metabolic syndromea 0.96 (0.52–1.76) 1 (ref.) 1.05 (0.73–1.50) 1.49 (1.02–2.17) – 0.185 0.410
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born small for gestational age (SGA) [38], while another 
reported higher adiponectin levels in prepubertal chil-
dren born SGA compared to children born with low 
weight adequate for gestational age [39]. In our study, no 
association was found between birth weight and plasma 
adiponectin levels, suggesting that adiponectin does 
not mediate the associations between low or high birth 
weight and diabetes or obesity risk in middle-aged peo-
ple, a finding also reported by others [6, 39–41]. Further 
studies are needed to better understand the potential link 
between adiponectin and birth weight, by notably evalu-
ating the role of catch-up growth in this process.
Birth weight and markers of glucose homeostasis
The association of markers of glucose homeostasis with 
low birth weight remained after adjustment for obe-
sity markers, suggesting that low birth weight increases 
diabetes risk through mechanisms that are independ-
ent of obesity or body composition, warranting further 
research. It has been suggested that people born with a 
low weight tend to have a more visceral distribution of 
obesity and significantly reduced muscle mass, with an 
increased body fat content [42]. A study suggested that 
low fat deposition leading to thinness at birth and during 
infancy results in fat acquisition during childhood, with a 
subsequent increase in the risk of developing type 2 dia-
betes [43]. Indeed, a higher waist circumference and per-
centage of body fat were observed in women born with a 
low weight, but not in men. Moreover, women born with 
a low weight also presented higher BMI and obesity lev-
els. Hence, although our findings partly confirm that peo-
ple born with a low weight tend to present a higher body 
fat content and diabetes risk, further studies are needed 
to better assess this point, namely regarding the differ-
ences between genders. An important confounder could 
be catch-up growth during the first years of life, as it is 
more closely linked to adult adiposity than birth weight 
[44–47].
Possible impact on cardiovascular disease
Low birth weight has been shown to be significantly 
associated with increased all-cause mortality in both 
genders and with increased cardiovascular mortality in 
men [48]. The higher leptin levels observed among par-
ticipants born with a low weight might partly contrib-
ute to this observation, as higher leptin levels have been 
shown to be an independent risk factor for cardiovascu-
lar disease among diabetic patients [49, 50]. Low birth 
weight might also impact vascular endothelium proper-
ties [51] and increases the risk of obesity and type 2 dia-
betes [52], probably via a common genetic mechanism 
[53, 54]. Further, earlier age at menarche among obese 
adolescents might also be an independent risk factor 
for the development of type 2 diabetes and cardiometa-
bolic disease [55]. Overall, our results suggest that people 
born with a low weight should be counselled regarding 
the risks of developing diabetes and/or cardiovascular 
disease.
Study limitations
Our study has several limitations. First, the participa-
tion rate was low (41  %), which might limit the gener-
alization of the findings; yet, this participation rate is in 
line with other epidemiological studies [56]. In addition, 
the distribution of age groups 35–54 and 55–75 in the 
CoLaus study was comparable to the source population 
and there was no gender or zip code distribution differ-
ence between the source population and the CoLaus par-
ticipants (not shown). Second, self-reported birth weight 
was only available for a subset of participants that sub-
stantially differed from participants who did not provide 
this information. Third, no objective validation of the 
reported birth weights was performed, thus leading to a 
possible reporting bias. Still, it has been shown that the 
validity of self-reported birth weight is high [57]. Fourth, 
no information regarding gestational age at birth was col-
lected. Hence, it was not possible to distinguish between 
a low birth weight adequate for gestational age (AGA) 
from a low birth weight small for gestational age (SGA). 
This might have confounded our findings, as it has been 
shown that children born SGA already present with insu-
lin resistance and higher adiponectin levels at prepuber-
tal age, although no difference in leptin levels have been 
reported [39]. Finally, we could not evaluate the impact of 
catch-up growth in early life, as we could not record body 
weight gain during early infancy due to the nature of the 
CoLaus study.
Conclusion
Our results suggest that people born with a low weight 
present a higher prevalence of diabetes and that both low 
and high birth weight are associated with obesity mark-
ers, compared to people born with a normal weight. The 
higher leptin levels and higher leptin to fat mass ratio 
among people born with a low weight might be related to 
nutritional factors during childhood, leptin resistance, or 
to a higher leptin production by body fat unit.
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